SyntaLinker-Hybrid: A deep learning approach for target specific drug design
Target specific drug design has attracted much attention in drug discovery. But, it is a great challenge to efficiently explore the target-focused chemical space. Fragment-based drug design (FBDD) has shown its potential to do this thing. In this study, we introduced a deep learning-based fragment l...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-12-01
|
| Series: | Artificial Intelligence in the Life Sciences |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S266731852200006X |